Skip to main content
AAN.com

Abstract

Objective: To determine the types, relative frequencies, clinical features, and MRI characteristics of malformations of cortical development (MCD) occurring in a cohort of children referred to a tertiary pediatric center.
Methods: Original MR images were reviewed by two investigators, who were blinded to clinical details, to determine the elemental imaging features of each malformation and to label these malformations according to an existing system of classification. Clinical information was collected by a review of hospital records.
Results: A total of 109 children with MCD were identified. There were 58 boys and 51 girls, age 8 days to 18 years at initial imaging (mean age, 5 years). Seizures were present in 75%, developmental delay or intellectual disability in 68%, abnormal neurologic findings in 48%, and congenital anomalies apart from the CNS malformation in 18%. The main malformations identified were heterotopic gray matter (19%), cortical tubers (17%), focal cortical dysplasia (16%), polymicrogyria (16%), agyria/pachygyria (15%), schizencephaly/cleft (5%), transmantle dysplasia (5%), and hemimegalencephaly (4%). Eight patients had features of more than one malformation. Most lesions were multilobar (47%), with the frontal lobe being the most common lobe involved (78%). A total of 68% of patients had other cerebral malformations including ventricular dilatation or dysmorphism (46%) and abnormalities of the corpus callosum (29%).
Conclusions: This study illustrates the spectrum of MCD in a pediatric cohort and highlights some of the differences between pediatric and adult patients. Patients with MCD presenting in childhood have a wider spectrum of malformations and more varied, often more severe, clinical manifestations. The lesions are frequently multifocal or generalized and many are associated with noncortical developmental brain anomalies.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Brodtkorb E, Nilsen G, Smevik O, Rinck PA. Epilepsy and anomalies of neuronal migration MRI and clinical aspects. Acta Neurol Scand 1992;86:24–32.
2.
Sugimoto T, Woo M, Nishida N, et al. When do brain abnormalities in cerebral palsy occur? An MRI study. Dev Med Child Neurol 1995;37:285–292.
3.
Jay V, Becker LE. Surgical pathology of epilepsy a review. Pediatr Pathol 1994;14:731–750.
4.
Truwit CL, Barkovich AJ, Koch TK, Ferriero DM. Cerebral palsy MR findings in 40 patients. AJNR Am J Neuroradiol 1992;13:67–78.
5.
Palmini A, Andermann F, Olivier A, et al. Focal neuronal migration disorders and intractable partial epilepsy a study of 30 patients. Ann Neurol 1991;30:741–749.
6.
des Portes V, Pinard JM, Smadja D, et al. Dominant X linked subcortical laminar heterotopia and lissencephaly syndrome (XSCLH/LIS) evidence for the occurrence of mutation in males and mapping of a potential locus in Xq22. J Med Genet 1997;34:177–183.
7.
Kuzniecky RI, Andermann F, Guerrini R. Congenital bilateral perisylvian syndrome study of 31 patients. Lancet 1993;341:608–612.
8.
Barkovich AJ, Kuzniecky RI, Dobyns WB, Jackson GD, Becker LE, Evrard P. A classification scheme for malformations of cortical development. Neuropediatrics 1996;27:59–63.
9.
Barth PG. Disorders of neuronal migration. Can J Neurol Sci 1987;14:1–16.
10.
Kuzniecky RI. Magnetic resonance imaging in developmental disorders of the cerebral cortex. Epilepsia 1994;35:S44–S5.
11.
Dobyns WB, Truwit CL. Lissencephaly and other malformations of cortical development 1995 update. Neuropediatrics 1995;26:132–147.
12.
Ferrie CD, Jackson GD, Giannakodimos S, Panayiotopoulos CP. Posterior agyria–pachygyria with polymicrogyria evidence for an inherited neuronal migration disorder. Neurology 1995;45:150–153.
13.
Barkovich AJ, Chuang SH. Unilateral megaloencephaly correlation of MR imaging and pathologic characteristics. AJNR Am J Neuroradiol 1990;11:523–531.
14.
Livingston J, Aicardi J. Unusual MRI appearance of diffuse subcortical heterotopia or “double cortex” in two children. J Neurol Neurosurg Psychiatry 1990;33:617–620.
15.
Kuzniecky RI, Powers R. Epilepsia partialis continua due to cortical dysplasia. J Child Neurol 1993;8:386–388.
16.
Raymond AA, Fish DR, Sisodiya SM, Alsanjari N, Stevens JM, Shorvon SD. Abnormalities of gyration, heterotopias, tuberous sclerosis, focal cortical dysplasia, microdysgenesis, dysembryoplastic neuroepithelial tumour and dysgenesis of the archicortex in epilepsy—clinical, EEG and neuroimaging features in 100 adult patients. Brain 1995;118:629–660.
17.
Palmini A, Andermann F, Olivier A, et al. Neuronal migration disorders a contribution of modern neuroimaging to the etiologic diagnosis of epilepsy. Can J Neurol Sci 1991;18:580–587.
18.
Aicardi J. The place of neuronal migration abnormalities in child neurology—review article. Can J Neurol Sci 1994;21:185–193.
19.
American College of Radiology.Index for radiological diagnoses. 4th ed. Reston, VA:American College of Radiology, 1992.
20.
Taylor DC, Falconer MA, Bruton CJ, Corsellis JAN. Focal dysplasia of the cerebral cortex in epilepsy. J Neurol Neurosurg Psychiatry 1971;34:369–387.
21.
Kuzniecky RI, Garcia JH, Faught E, Morawetz RB. Cortical dysplasia in temporal lobe epilepsy magnetic resonance imaging correlations. Ann Neurol 1991;29:293–298.
22.
Vinters HV, Armstrong DL, Babb TL, et al. The neuropathology of human symptomatic epilepsy. In: Engel JJ, ed. Surgical treatment of the epilepsies. 2nd ed. New York:Raven Press, 1993:593–608.
23.
Barkovich AJ, Kuzniecky RI, Bollen AW, Grant PE. Focal transmantle dysplasia a specific malformation of cortical development. Neurology 1997;49:1148–1153.
24.
Eksioglu YZ, Scheffer IE, Cardenas P, et al. Periventricular heterotopia an X-linked dominant epilepsy locus causing aberrant cerebral cortical development. Neuron 1996;16:77–87.
25.
Dobyns WB, Andermann E, Andermann F, et al. X-linked malformations of neuronal migration. Neurology 1996;47:331–339.
26.
Smart IHM, Smart M. Growth patterns in the lateral wall of the mouse telencephalon I. Autoradiographic studies of the histogenesis of the isocortex and adjacent area. J Anat 1982;134:273–298.
27.
des Portes V, Pinard JM, Billuart P, et al. A novel CNS gene required for neuronal migration and involved in X-linked subcortical laminar heterotopia and lissencephaly syndrome. Cell 1998;92:51–61.
28.
Gleeson JG, Allen KM, Fox JW, et al. Doublecortin, a brain-specific gene mutated in human X-linked lissencephaly and double cortex syndrome, encodes a putative signaling protein. Cell 1998;92:63–72.
29.
Sossey–Alaoui K, Hartung AJ, Guerrini R, et al. Human doublecortin (DCX) and the homologous gene in mouse encode a putative Ca2+-dependent signaling protein which is mutated in human X-linked neuronal migration defects. Hum Mol Genet 1998;7:1327–1332.
30.
Pilz DT, Matsumoto N, Minnerath SR, et al. LIS1 and XLIS (DCX) mutations cause most classical lissencephaly, but different patterns of malformation. Hum Mol Genet 1998;7:2029–2037.
31.
Kuzniecky RI, Berkovic SF, Andermann F, Melanson D, Olivier A, Robitaille Y. Focal cortical myoclonus and Rolandic cortical dysplasia clarification by magnetic resonance imaging. Ann Neurol 1988;23:317–325.
32.
Ho SS, Kuzniecky RI, Gilliam F, Faught E, Morawetz R. Temporal lobe malformations and epilepsy dual pathology and bilateral hippocampal abnormalities. Neurology 1998;50:748–754.
33.
Li LM, Dubeau F, Andermann F, et al. Periventricular nodular heterotopia and intractable temporal lobe epilepsy poor outcome after temporal lobe resection. Ann Neurol 1997;41:662–668.
34.
Volpe JJ. Neuronal proliferation, migration, organization and myelination. In: Volpe JJ, ed. Neurology of the newborn. 3rd ed. Philadelphia:WB Saunders, 1995:43–92.
35.
Hayward JC, Titelbaum DS, Clancy RR, Zimmerman RA. Lissencephaly–pachygyria associated with congenital cytomegalovirus infection. J Child Neurol 1991;6:109–114.

Information & Authors

Information

Published In

Neurology®
Volume 53Number 4September 1, 1999
Pages: 715
PubMed: 10489031

Publication History

Received: January 7, 1999
Accepted: March 27, 1999
Published online: September 1, 1999
Published in print: September 1, 1999

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

R.J. Leventer, FRACP
From the Departments of Neurology (Drs. Leventer and Harvey) and Radiology (Drs. PhelanColeman, and Kean), Royal Children’s Hospital, Melbourne; the Brain Imaging Research Institute Austin and Repatriation Medical Centre (Dr. Jackson), Melbourne; and the Departments of Pediatrics (Drs. Leventer and Harvey) and Medicine (Dr. Jackson), University of Melbourne, Australia.
E.M. Phelan, FRCR
From the Departments of Neurology (Drs. Leventer and Harvey) and Radiology (Drs. PhelanColeman, and Kean), Royal Children’s Hospital, Melbourne; the Brain Imaging Research Institute Austin and Repatriation Medical Centre (Dr. Jackson), Melbourne; and the Departments of Pediatrics (Drs. Leventer and Harvey) and Medicine (Dr. Jackson), University of Melbourne, Australia.
L.T. Coleman, FRACR
From the Departments of Neurology (Drs. Leventer and Harvey) and Radiology (Drs. PhelanColeman, and Kean), Royal Children’s Hospital, Melbourne; the Brain Imaging Research Institute Austin and Repatriation Medical Centre (Dr. Jackson), Melbourne; and the Departments of Pediatrics (Drs. Leventer and Harvey) and Medicine (Dr. Jackson), University of Melbourne, Australia.
M.J. Kean, DipAppSci
From the Departments of Neurology (Drs. Leventer and Harvey) and Radiology (Drs. PhelanColeman, and Kean), Royal Children’s Hospital, Melbourne; the Brain Imaging Research Institute Austin and Repatriation Medical Centre (Dr. Jackson), Melbourne; and the Departments of Pediatrics (Drs. Leventer and Harvey) and Medicine (Dr. Jackson), University of Melbourne, Australia.
G.D. Jackson, FRACP
From the Departments of Neurology (Drs. Leventer and Harvey) and Radiology (Drs. PhelanColeman, and Kean), Royal Children’s Hospital, Melbourne; the Brain Imaging Research Institute Austin and Repatriation Medical Centre (Dr. Jackson), Melbourne; and the Departments of Pediatrics (Drs. Leventer and Harvey) and Medicine (Dr. Jackson), University of Melbourne, Australia.
A.S. Harvey, FRACP
From the Departments of Neurology (Drs. Leventer and Harvey) and Radiology (Drs. PhelanColeman, and Kean), Royal Children’s Hospital, Melbourne; the Brain Imaging Research Institute Austin and Repatriation Medical Centre (Dr. Jackson), Melbourne; and the Departments of Pediatrics (Drs. Leventer and Harvey) and Medicine (Dr. Jackson), University of Melbourne, Australia.

Notes

Address correspondence and reprint requests to Dr. A. Simon Harvey, Department of Neurology, Royal Children’s Hospital, Flemington Road, Parkville, Victoria, 3052 Australia; e-mail: [email protected]

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. The role of axon guidance molecules in the pathogenesis of epilepsy, Neural Regeneration Research, 20, 5, (1244-1257), (2024).https://doi.org/10.4103/NRR.NRR-D-23-01620
    Crossref
  2. Structural brain abnormalities in Pallister-Killian syndrome: a neuroimaging study of 31 children, Orphanet Journal of Rare Diseases, 19, 1, (2024).https://doi.org/10.1186/s13023-024-03065-5
    Crossref
  3. Heterogeneous genetic patterns in bilateral perisylvian polymicrogyria: insights from a Finnish family cohort, Brain Communications, 6, 3, (2024).https://doi.org/10.1093/braincomms/fcae142
    Crossref
  4. Diagnostic utility of exome sequencing followed by research reanalysis in human brain malformations, Brain Communications, 6, 2, (2024).https://doi.org/10.1093/braincomms/fcae056
    Crossref
  5. Polymicrogyria, Cobblestone Malformations, and Tubulin Mutation (Overmigration beyond Pial Limiting Membrane): Diagnosis, Treatment, and Rehabilitation Approach, Journal of Pediatric Neurology, (2024).https://doi.org/10.1055/s-0044-1786999
    Crossref
  6. Epileptogenesis and drug-resistant in focal cortical dysplasias: Update on clinical, cellular, and molecular markers, Epilepsy & Behavior, 150, (109565), (2024).https://doi.org/10.1016/j.yebeh.2023.109565
    Crossref
  7. Language and communication functioning in children and adolescents with agenesis of the corpus callosum, Brain and Language, 255, (105448), (2024).https://doi.org/10.1016/j.bandl.2024.105448
    Crossref
  8. Bridging Development and Disruption: Comprehensive Insights into Focal Cortical Dysplasia and Epileptic Management, Cureus, (2023).https://doi.org/10.7759/cureus.45996
    Crossref
  9. Expression of Cytoskeletal Proteins (GFAP, Vimentin), Proapoptotic Protein (Caspase-3) and Protective Protein (S100) in the Epileptic Focus in Adults and Children with Drug-Resistant Temporal Lobe Epilepsy Associated with Focal Cortical Dysplasia, International Journal of Molecular Sciences, 24, 19, (14490), (2023).https://doi.org/10.3390/ijms241914490
    Crossref
  10. Case report: Genotype and phenotype of DYNC1H1-related malformations of cortical development: a case report and literature review, Frontiers in Neurology, 14, (2023).https://doi.org/10.3389/fneur.2023.1163803
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share